Trial Profile
A Multi-institutional, Randomized Controlled, Phase II Clinical Trial on Comparison of Efficacy and Safety of Nedaplatin Plus 5-Fu Combined With and Without Endostar Continuous Intravenous Infusion in Refractory Nasopharyngeal Carcinoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2020
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Fluorouracil; Nedaplatin
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 30 Oct 2015 New trial record